Infantile Malignant Osteopetrosis: Delay in Diagnosis Eliminates Chance of Cure

Insights

Infantile malignant osteopetrosis, a rare bone disorder, presents severe symptoms and complications. Delayed diagnosis prevented bone marrow transplantation, highlighting the need for early detection in affected children.

Area of Science:

  • Pediatric Hematology
  • Pediatric Neurology
  • Skeletal Dysplasias

Background:

  • Infantile malignant osteopetrosis is a rare genetic disorder characterized by impaired osteoclast function, leading to bone sclerosis.
  • The patient presented with a complex medical history including meningitis, hydrocephalus, and tethered cord syndrome, complicating the diagnostic pathway.

Purpose of the Study:

  • To report a challenging case of infantile malignant osteopetrosis with significant neurological and developmental comorbidities.
  • To highlight the diagnostic delays and their impact on treatment options, specifically bone marrow transplantation.

Main Methods:

  • Clinical case presentation detailing the patient's history, physical examination findings, and diagnostic workup.
  • Review of diagnostic imaging (roentgenograms) and bone marrow biopsy results.

Main Results:

  • The patient exhibited failure to thrive, hepatosplenomegaly, leukoerythroblastic anemia, thrombocytopenia, and bone sclerosis.
  • Diagnosis of infantile malignant osteopetrosis was confirmed, but bone marrow transplantation was not feasible due to irreversible complications and lack of medullary space.

Conclusions:

  • Early diagnosis of infantile malignant osteopetrosis is crucial for timely intervention and improved outcomes.
  • Multisystemic involvement and diagnostic delays can preclude curative treatments like bone marrow transplantation in severe cases.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.9K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
995
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
6.3K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K